Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.

Scharf, Martin; Rogowski, Roberta; Hull, Steven; Cohn, Martin; Mayleben, David; Feldman, Neil; Ereshefsky, Larry; Lankford, Alan; Roth, Thomas

Scharf, Martin; Rogowski, Roberta; Hull, Steven; Cohn, Martin; Mayleben, David; Feldman, Neil; Ereshefsky, Larry; Lankford, Alan; Roth, Thomas.

Affiliation

Scharf M; Tristate Sleep Disorders Center, 1275 East Kemper Rd., Cincinnati, OH 45246, USA. sleepsat1@aol.com

J Clin Psychiatry ; 69(10): 1557-64, 2008 Oct.

Article in En | MEDLINE | ID: mdl-19192438

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxepin / Histamine Antagonists / Sleep Initiation and Maintenance Disorders Type of study: Clinical_trials Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Clin Psychiatry Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links